TLCM

Twin Lakes Capital Management Portfolio holdings

AUM $164M
1-Year Return 20.56%
This Quarter Return
-6.87%
1 Year Return
+20.56%
3 Year Return
+72.84%
5 Year Return
10 Year Return
AUM
$124M
AUM Growth
-$14.1M
Cap. Flow
-$16.9M
Cap. Flow %
-13.62%
Top 10 Hldgs %
41.3%
Holding
300
New
150
Increased
41
Reduced
12
Closed
45

Sector Composition

1 Technology 20.73%
2 Consumer Discretionary 14.48%
3 Industrials 14.07%
4 Healthcare 13.39%
5 Financials 12.9%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRH icon
226
CRH
CRH
$75.4B
$5K ﹤0.01%
+148
New +$5K
ESS icon
227
Essex Property Trust
ESS
$17.3B
$5K ﹤0.01%
+20
New +$5K
JJSF icon
228
J&J Snack Foods
JJSF
$2.12B
$5K ﹤0.01%
+41
New +$5K
PBI icon
229
Pitney Bowes
PBI
$2.11B
$5K ﹤0.01%
+2,000
New +$5K
FRC
230
DELISTED
First Republic Bank
FRC
$5K ﹤0.01%
+36
New +$5K
IR icon
231
Ingersoll Rand
IR
$32.2B
$4K ﹤0.01%
100
FBIN icon
232
Fortune Brands Innovations
FBIN
$7.3B
$3K ﹤0.01%
74
+1
+1% +$41
OGN icon
233
Organon & Co
OGN
$2.7B
$3K ﹤0.01%
+118
New +$3K
RYAAY icon
234
Ryanair
RYAAY
$32.1B
$3K ﹤0.01%
+115
New +$3K
VEEV icon
235
Veeva Systems
VEEV
$44.7B
$3K ﹤0.01%
+16
New +$3K
HBI icon
236
Hanesbrands
HBI
$2.27B
$2K ﹤0.01%
+300
New +$2K
KD icon
237
Kyndryl
KD
$7.57B
$2K ﹤0.01%
+296
New +$2K
SPGI icon
238
S&P Global
SPGI
$164B
$2K ﹤0.01%
+8
New +$2K
VTGN icon
239
VistaGen Therapeutics
VTGN
$109M
$2K ﹤0.01%
+417
New +$2K
ADBE icon
240
Adobe
ADBE
$148B
$2K ﹤0.01%
6
BHC icon
241
Bausch Health
BHC
$2.72B
$2K ﹤0.01%
300
CHI
242
Calamos Convertible Opportunities and Income Fund
CHI
$816M
$2K ﹤0.01%
+232
New +$2K
CMCSA icon
243
Comcast
CMCSA
$125B
$2K ﹤0.01%
+63
New +$2K
AMRN
244
Amarin Corp
AMRN
$317M
$1K ﹤0.01%
+50
New +$1K
EEFT icon
245
Euronet Worldwide
EEFT
$3.74B
$1K ﹤0.01%
+8
New +$1K
HPE icon
246
Hewlett Packard
HPE
$31B
$1K ﹤0.01%
+63
New +$1K
OTIS icon
247
Otis Worldwide
OTIS
$34.1B
$1K ﹤0.01%
+23
New +$1K
SE icon
248
Sea Limited
SE
$113B
$1K ﹤0.01%
20
UUUU icon
249
Energy Fuels
UUUU
$2.67B
$1K ﹤0.01%
110
TNXP icon
250
Tonix Pharmaceuticals
TNXP
$233M
0